Related Experiment Video
Updated: Jan 24, 2026

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
Published on: August 17, 2010
In silico signaling modeling to understand cancer pathways and treatment responses
Meik Kunz1, Julian Jeromin2, Maximilian Fuchs2
1Chair of Medical Informatics, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
Abstract:
Precision medicine has changed thinking in cancer therapy, highlighting a better understanding of the individual clinical interventions. But what role do the drivers and pathways identified from pan-cancer genome analysis play in the tumor? In this letter, we will highlight the importance of in silico modeling in precision medicine. In the current era of big data, tumor engines and pathways derived from pan-cancer analysis should be integrated into in silico models to understand the mutational tumor status and individual molecular pathway mechanism at a deeper level. This allows to pre-evaluate the potential therapy response and develop optimal patient-tailored treatment strategies which pave the way to support precision medicine in the clinic of the future.
Insights
In silico modeling is crucial for precision medicine, integrating pan-cancer data to analyze tumor mutations and pathways. This approach aids in predicting therapy response and developing personalized cancer treatments.
Area of Science:
- Oncology
- Bioinformatics
- Computational Biology
Background:
- Precision medicine advances cancer therapy by focusing on individual patient molecular profiles.
- Pan-cancer genome analysis identifies key tumor drivers and molecular pathways.
- Understanding the role of these identified drivers and pathways in individual tumors is critical.
Discussion:
- In silico modeling offers a powerful approach to integrate big data from pan-cancer analyses.
- These models can elucidate complex mutational tumor status and individual molecular pathway mechanisms.
- Integrating genomic data into computational models enhances our understanding of tumor biology.
Key Insights:
- Tumor engines and pathways from pan-cancer analysis should be incorporated into in silico models.
- In silico models allow for a deeper understanding of individual molecular pathway mechanisms.
- This integration facilitates the pre-evaluation of potential therapy responses.
Outlook:
- In silico modeling supports the development of optimal patient-tailored treatment strategies.
- This approach is vital for advancing precision medicine in future clinical practice.
- Computational tools are essential for realizing the full potential of personalized cancer therapy.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway
Nitric Oxide Signaling Pathway